Illumina has acquired digital microfluidics company Advanced Liquid Logic (ALL), the firm said today. Through the acquisition, ALL will become a wholly owned subsidiary of Illumina. Financial terms were not disclosed.

The San Diego sequencing giant noted that ALL’s digital microfluidics technology is based on an electrowetting approach “that precisely manipulates small droplets within a sealed disposable cartridge to perform complex laboratory protocols.” The company added that ALL’s technology has been used for a variety of applications, from nucleic acid isolation to library generation for next-generation sequencing.

Illumina said the addition of ALL’s technology to portfolio “will further streamline” its next-generation sequencing workflow customer offerings.

“For clinical and applied markets, where ease of use and consistency are especially valued, it will allow us to offer integrated, end-to-end solutions,” Christian Henry, svp, general manager of Illumina’s Genomic Solutions business, said in a statement. “ALL brings an impressive IP portfolio in digital microfluidics and a talented team with a track record of innovation.”

Previous articleNIH Ushering Genome Sequencing Toward the Clinic with Grants Totaling $27M
Next articleNew Gene Patent Suit Sparks Talk of Trolls